Retension Pharmaceuticals, Inc. (NASDAQ:RTSN) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Franklin Berger Other companies: Atea Pharmaceuticals, Inc. (Director · Since at least Oct 29, 2020); ESSA Pharma Inc (Director · Since at least Oct 1, 2020); Kezar Life Sciences, Inc. (Director · Since at least Jun 25, 2019); Rain Oncology Inc (Director · Apr 22, 2021 – Jan 26, 2024 · Past); Kineta Inc. (Director · Jun 27, 2019 – Jun 29, 2020 · Past); Atreca Inc (Director · Jun 19, 2019 – Jun 13, 2023 · Past); Five Prime Therapeutics Inc (Director · Jun 10, 2019 – Apr 16, 2021 · Past); Tocagen Inc (Director · May 29, 2019 – Oct 4, 2019 · Past); Immune Design Corp (Director · Apr 2, 2019 – Apr 2, 2019 · Past) | Director · Since at least Oct 13, 2026 |
| Michael J Berendt Other companies: Waters Corporation (Director · May 15, 2013 – Aug 13, 2021 · Past) | Director · Since at least Oct 13, 2026 |
| Alex Schwartz | Chief Financial Officer · Since at least Nov 4, 2026 |
| Alison D. Schecter | Chief Medical Officer · Since at least Nov 4, 2026 |
| Donald Olds | Director · Since at least Oct 13, 2026 |
| Eric Keller | CHIEF EXECUTIVE OFFICER, Director · Since at least Oct 13, 2026 |
| Kevin Schutz | Vice President, Regulatory Affairs · Since at least Nov 4, 2026 |
| LeAnne Bloedon | Executive Vice President, Clinical Development and Operations · Since at least Nov 4, 2026 |
| Paul Sweetnam | CHIEF SCIENTIFIC OFFICER · Since at least Oct 13, 2026 |
| Pavan Cheruvu | Director · Since at least Nov 5, 2026 |
| Sabine Bisson | CHIEF OPERATING OFFICER · Since at least Oct 13, 2026 |